Weight-loss, Diabetes Drugs GLP-1: Govt Flags Serious Health Risks, Tightens Rules amid Rising Misuse and Safety Concerns Moneylife Digital Team 01 April 2026 The Indian government has issued a strong warning against the misuse of glucagon-like peptide-1 receptor agonists (GLP-1) drugs, widely used for treating type-2 diabetes and obesity, while stepping up regulatory action to curb their unauthorised sale across India
Presented for research literature review only Di Girolamo M et al
They also reflect what is happening in the brain's signaling pathways, hormone balance, sleep patterns, and overall health
When to see a doctor for Rosacea treatment You should see a doctor for rosacea treatment if: 1
Late diagnosis lag, high invasiveness, chemical resistance, and poor prognosis are unresolved issues of PC